Cargando…
Immunoexpression of the GCDFP-15 Marker in Different Grades of Breast Carcinoma
BACKGROUND & OBJECTIVE: During the last decade, biological markers of breast cancer have been considered to predict the degree of histology, behavior, and extent of tumor invasion and the possibility of lymph node involvement. The aim of this study was to evaluate the expression of GCDFP-15 in d...
Autores principales: | Shirian, Faeze, Kheradmand, Parvin, Ranjbari, Nastaran, Shahbazian, Hodjatollah, Latifi, Seyed Mahmoud |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Society of Pathology
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10293600/ https://www.ncbi.nlm.nih.gov/pubmed/37383152 http://dx.doi.org/10.30699/ijp.2023.558196.2945 |
Ejemplares similares
-
Evaluation of GATA3 and GCDFP15 Expression in Triple Negative Breast Cancers
por: Ahadi, Mahsa, et al.
Publicado: (2023) -
Gross cystic disease fluid protein 15 (GCDFP-15) expression in breast cancer subtypes
por: Darb-Esfahani, Silvia, et al.
Publicado: (2014) -
Gross Cystic Disease Fluid Protein-15 (GCDFP-15) Expression Characterizes Breast Mucinous Carcinomas in Older Women
por: Kinoshita, Mayumi, et al.
Publicado: (2022) -
Comparison of GATA-3, Mammaglobin and GCDFP-15 Expression in Primary, Metastatic and Triple Negative Breast Carcinomas: An Indian Scenario
por: Rao, Meenakshi, et al.
Publicado: (2023) -
Molecular apocrine breast cancers are aggressive estrogen receptor negative tumors overexpressing either HER2 or GCDFP15
por: Lehmann-Che, Jacqueline, et al.
Publicado: (2013)